Privacy Policy
Purpose of Privacy Statement

Bristol-Myers Squibb and AstraZeneca have entered into a Codevelopment and Copromotion Agreement for certain investigational compound(s). Bristol-Myers Squibb and AstraZeneca respect the privacy of visitors to this Web site and understand the importance of protecting your personal information. Bristol-Myers Squibb and AstraZeneca will not transfer, sell, or rent your personally identifiable information, except as specifically provided in this Privacy Statement. This Privacy Statement applies to personally identifiable information about you, such as name, postal address, telephone number, e-mail address, date of birth, or other information such as your education level or personal medical information (“Information”) that you voluntarily provide to us and that is collected online through this Web site only.

We encourage you to read this Privacy Statement before using this Web site or submitting Information. By using this Web site, you acknowledge that you understand and agree to the terms of this Privacy Statement.

Information Voluntarily Provided by Users

You can visit much of the Web site without telling us who you are or providing us with Information. Some areas of the Web site allow you to contact us to ask questions or provide comments. When you communicate with us and request a response, we ask for certain Information. If you do not wish to be contacted after we have fulfilled your request, you may call 1-888-281-9014.

Some areas of the Web site may also require that you submit Information in order to access specific content, features, interactive tools, or services or to participate in a particular activity. For example, to create an online account or to subscribe to a newsletter, we may ask for Information so we can tailor our response to your request.

In addition, when you access certain interactive tools or services, you may be asked to provide Information. You may always choose not to provide the required Information, but then you may not be able to participate in that particular activity.

We may personalize and customize this Web site for certain visitors. If you provide Information about yourself via a contact form, you may find it customized with references to products and/or services that we believe may be of interest to you, based on your previous interactions and Information you have provided to us. If you do provide us with Information, you agree that we may contact you through a variety of means such as postal mail, phone, or e-mail unless you opt out of this service by contacting us as indicated below.

We may share your Information with one of our other Bristol-Myers Squibb and AstraZeneca affiliated companies. We may also occasionally transfer or share your Information with third parties and affiliates who provide services to Bristol-Myers Squibb and AstraZeneca. Such third parties have or will agree to only use the Information on behalf of Bristol-Myers Squibb and AstraZeneca.

Use and Disclosure of Non–Personally Identifiable Information

Bristol-Myers Squibb and AstraZeneca will not treat as confidential any information that you provide that is not personally identifiable, such as questions, comments, ideas, or suggestions. You should be aware that such information will be the sole property of Bristol-Myers Squibb and AstraZeneca. By providing such information to Bristol-Myers Squibb and AstraZeneca, you understand and agree that no relationship has been created between Bristol-Myers Squibb and AstraZeneca and you, and Bristol-Myers Squibb and AstraZeneca have no obligation to you whatsoever regarding that information.

Update and Correction of Information

Other than the limited type of Information described below under the Regulatory Requirements section, you may contact us to update or correct your Information or to opt out from our mailings and other services that you may have signed up for. To do so, please contact us at 1-888-281-9014.


We take reasonable precautions to maintain the protection of Information collected through this Web site and used in accordance with this Privacy Statement. In addition to technical safeguards, we also use physical controls and procedures to safeguard your Information. However, we cannot guarantee that it is completely secure from people who might attempt to evade our security measures or intercept transmissions over the Internet. The use of this Web site is solely at your own risk.

Use of Cookies

We may store some information on your computer using a technique your browser supports called “cookies.” The cookies are used for a variety of purposes, including, but not limited to, helping you log in (eg, remembering your user name if you register or log in), remembering some of your customized user preferences, to help us better understand how people use our Web site, and to help us improve our Web site. In some cases, this information will help us tailor content to your interests or help us avoid asking for the same information when you revisit our Web site. The cookies set by our Web sites are used only by our Web sites. To disable or limit the use of cookies, please refer to the options provided by your Internet browser. If you do so, however, some pages on this Web site may not work properly.

Web Beacons

A Web Beacon is a clear GIF (Graphics Interchange Format) image or pixel tag that companies place on their Web sites to allow an Internet advertising or audience measurement company to help them analyze their advertising campaigns and general usage patterns of visitors to their Web sites. Bristol-Myers Squibb and AstraZeneca use Web Beacons on some of their Web sites.

Web Server Logging and IP Addresses

With or without cookies, our Web site keeps track of usage data, such as the source address that a page request is coming from (ie, your IP address, domain name), date and time of the page request, the referring Web site (if any), and other parameters in the URL (eg, search criteria). We use this data to better understand Web site usage on the whole and to determine which areas of our Web site users prefer (eg, based on the number of visits to those areas). This information is stored in log files and is used by Bristol-Myers Squibb and AstraZeneca for statistical reporting.

Transfer of Control

Circumstances may arise where we decide to reorganize or divest part or all of our business or of a line of our business, including our information databases and Web sites, through a sale, divestiture, merger, acquisition, or other means of transfer. In any such circumstance, personally identifiable Information may be shared with, sold, transferred, rented, licensed, or otherwise provided or made available by us or on our behalf to actual or potential parties to, and in connection with, the contemplated transaction (without your consent or any further notice to you). In such circumstances, we will seek written assurances that Information submitted through this Web site will be protected appropriately.

Regulatory Requirements

If you contact us regarding your experience, or the experience of your patients, with the use of any of our products, we may use the Information you provide in submitting reports to the US Food and Drug Administration, and as otherwise required of us by law or governmental audit. You understand that, in order to comply with the law, Bristol-Myers Squibb and AstraZeneca may not be permitted to comply with your request to amend or remove Information that you provided to Bristol-Myers Squibb and AstraZeneca regarding an adverse event or reaction involving medicine, medical products, or medical devices.

Law Enforcement

In rare situations, we may be required by court order or other legal or regulatory process, or as otherwise required by law, to divulge Information to law enforcement authorities, the courts, or regulatory authorities. Bristol-Myers Squibb and AstraZeneca will cooperate in responding to such requests, in accordance with the regulatory or legal process, and will take appropriate measures to ensure that the requester understands the sensitive nature of any health-related Information they receive. Bristol-Myers Squibb and AstraZeneca may also use Information to investigate and help prevent unlawful activity or activity that threatens the integrity and proper functioning of this Web site. Bristol-Myers Squibb and AstraZeneca may disclose your identity to third parties (such as the police) for these purposes. Bristol-Myers Squibb and AstraZeneca may monitor or record your communications with us for these, and quality control and training, purposes.

Privacy Policies Governing Linked Web Sites

As a convenience to our visitors, the Web site contains links to other Web sites that may offer useful information. This Internet Privacy Statement does not apply to your use of those other Web sites. Before using the linked Web sites, please review their Internet privacy statements to understand how they use and protect personally identifiable information.


You can choose to use a “tell-a-friend” or referral function on our Web site to let someone else know about this Web site or a product. In such case, we will ask for your friend’s name and e-mail address, as well as Information about you. The Information that you may provide for a friend will be used to send an e-mail on your behalf and will not be collected or stored by Bristol-Myers Squibb or AstraZeneca for any additional purpose.

Changes in Our Privacy Statement

Bristol-Myers Squibb and AstraZeneca may at any time revise this Privacy Statement by updating this posting. You are bound by any such revisions and should therefore periodically visit this page to review the most current Privacy Statement.

Online Privacy for Children

We are committed to protecting the privacy of children. We do not intend to collect personally identifiable Information from children under 13 years old. If a child has provided us with personally identifiable Information, the parent or guardian of that child may contact us at 1-888-281-9014.


If you have any questions about this Privacy Statement or other aspects of privacy on our Web site, please contact us at 1-888-281-9014.

for ONGLYZA (saxagliptin)

Do not take ONGLYZA (saxagliptin) if you are allergic to any of its ingredients. Serious allergic reactions can occur with ONGLYZA and may include swelling of the face, lips or throat, difficulty swallowing or breathing, swelling of the skin, hives, rash, itching, flaking, or peeling. If you have these symptoms, stop taking ONGLYZA and contact your doctor right away.

Serious side effects can happen to people taking ONGLYZA, including inflammation of the pancreas (pancreatitis) which may be severe and lead to death. Before taking ONGLYZA, tell your doctor if you ever had pancreatitis, gallstones, history of alcoholism, or high triglyceride levels. Stop taking ONGLYZA and contact your doctor right away if you have pain in your stomach area (abdomen) that is severe and will not go away. The pain may be felt going from your abdomen through to your back. The pain may happen with or without vomiting. These may be symptoms of pancreatitis.


ONGLYZA (saxagliptin) is a prescription medicine used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.

ONGLYZA should not be used to treat people with type 1 diabetes or diabetic ketoacidosis (increased ketones in the blood or urine).

If you have had inflammation of the pancreas (pancreatitis), it is not known if you have a higher chance of getting pancreatitis while taking ONGLYZA.

When ONGLYZA is used with certain other diabetes medicines to treat high blood sugar, such as a sulfonylurea or insulin, the risk of low blood sugar (hypoglycemia) is higher. Symptoms of low blood sugar include shaking, hunger, sweating, headache, rapid heartbeat, change in mood, and change in vision. Follow your doctor’s instructions for treating low blood sugar.

When ONGLYZA is used with a thiazolidinedione (TZD), such as pioglitazone or rosiglitazone, to treat high blood sugar, peripheral edema (fluid retention) may become worse. If you have symptoms of peripheral edema, such as swelling of hands, feet, or ankles, call your doctor.

The most common side effects with ONGLYZA include upper respiratory tract infection, urinary tract infection, and headache.

Your doctor should test your blood to measure how well your kidneys are working before and during treatment with ONGLYZA. You may need a lower dose if your kidneys are not working well.

Tell your doctor if you start or stop taking other medications, including antibiotics, antifungals or HIV/AIDS medications, as your doctor may need to change your dose of ONGLYZA.

Tell your doctor if you are pregnant, breast-feeding, or plan to become pregnant or breast-feed.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit, or call 1-800-FDA-1088.

Please click here for Medication Guide, and click here for US Full Prescribing Information for ONGLYZA (saxagliptin).

This product information is intended for US customers only.

©2013 AstraZeneca Pharmaceuticals LP and Bristol-Myers Squibb Company.

ONGLYZA® is a trademark of Bristol-Myers Squibb Company.

422US13BR01333-01-01 06/13

US Full Prescribing Information   Medication Guide  Unsubscribe  Privacy Statement  Legal Notice   Site Map

BMS Logo AstraZeneca Logo

Bristol-Myers Squibb Patient Assistance Foundation:
This non-profit organization provides assistance to
qualifying patients with financial hardship who generally
have no prescription insurance. Contact 1-800-736-0003
or visit for more information.